Brookfield Set to Drop Grifols Bid as Family Shuns Others
This article is for subscribers only.
Brookfield Asset Management Ltd. is preparing to walk away from a plan to acquire Grifols SA over disagreements on valuation. The Spanish company’s billionaire founding family said it won’t support any new bid to take its namesake drug-maker private.
New York-based Brookfield decided to end months of negotiations, which were disclosed publicly in July, after failing to reach an agreement with the board of Grifols on the price, according to people familiar with the matter. The money manager had lined up financing for the deal and prepared a turnaround plan for the business, according to the people, who cannot be named as the matter isn’t public.